0 items USD 0.00Search
Your search for "gir global hemophilia gene therapy market 2018 manufacturers countries type application forecast" gave back 83406 results.
Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a...
Catalog:
GIR
January 2023
Price: USD 3,480.00
The global Hemophilia Gene Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a...
Catalog:
MRRPB5
November 2023
Price: USD 4,350.00
Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a...
Catalog:
MRRPB5
January 2023
Price: USD 4,000.00
Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
The global Hemophilia Gene Therapy market size was valued at US$ million in 2023. With growing demand in downstream market, the Hemophilia Gene...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global AAV Vector Gene Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a...
Catalog:
GIR
November 2023
Price: USD 3,480.00
Hemophilia is a hereditary genetic disorder which impairs body’s ability to control coagulation or blood clotting. In this disease, clotting factors...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Hemophilia is a hereditary genetic disorder which impairs body’s ability to control coagulation or blood clotting. In this disease, clotting factors...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global AAV Vector Gene Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period...
Catalog:
GIR
November 2023
Price: USD 4,480.00
Hemophilia is a hereditary genetic disorder which impairs body’s ability to control coagulation or blood clotting. In this disease, clotting factors...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Summary Publisher estimates that the Hemophilia Treatment market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a...
Catalog:
HYR
June 2021
Price: USD 2,000.00
